Serum Fibroblast Growth Factor 21 Levels Are Positively Associated with Metabolic Syndrome in Patients with Type 2 Diabetes.

Ruo-Yao GaoBang-Gee HsuDu-An WuJia-Sian HouMing-Chun Chen

Published in: International journal of endocrinology (2019)

This study showed that higher serum FGF21 levels were positively associated with MetS in T2DM patients and significantly positively related to body fat mass and TG but negatively related to eGFR in these subjects.

Keyphrases

metabolic syndrome
end stage renal disease
ejection fraction
small cell lung cancer
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
epidermal growth factor receptor
cardiovascular disease
insulin resistance
patient reported outcomes
skeletal muscle
adipose tissue
weight loss